Silence Therapeutics plc (SLN) Tops Q2 EPS by 5c

Silence Therapeutics plc (NASDAQ: SLN) reported Q2 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Silence Therapeutics plc (SLN) click here.

You May Also Be Interested In

• Raymond James Starts Rocket Lab USA (RKLB) at Outperform
• RH shares jump after second quarter beat
• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance